TOVX – theriva biologics, inc. (US:NASDAQ)
Stock Stats
News
Theriva™ Biologics Announces U.S. FDA Guidance on Design of Phase 3 Study of VCN-01 for the Treatment of Metastatic Pancreatic Cancer [Yahoo! Finance]
Theriva™ Biologics Announces U.S. FDA Guidance on Design of Phase 3 Study of VCN-01 for the Treatment of Metastatic Pancreatic Cancer
SOHM, Inc. Announces Allowances Of Japanese Patent Claims Received from Japan's Patent Office (???, Tokkyocho, JPO) Protecting Transformative SOHM-ABBIE Genome Edited, SAGE Recombinant-Organisms, -Cells, -Secretomes, -Exosomes [Yahoo! Finance]
Theriva Biologics GAAP EPS of -$6.81 [Seeking Alpha]
Theriva™ Biologics Reports Third Quarter 2024 Operational Highlights and Financial Results
Form S-1 Theriva Biologics, Inc.
Form 8-K Theriva Biologics, Inc. For: Dec 05
Form S-8 Theriva Biologics, Inc.
Form 10-Q Theriva Biologics, Inc. For: Sep 30
Form 8-K Theriva Biologics, Inc. For: Nov 12
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.